| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882808 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 28 Pages |
Abstract
Current state-of-the art management of Ph+ ALL in real-life seems to be incorporation of TKIs to chemotherapy regimens and proceeding to allo-HCT, whenever possible.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Emre Tekgündüz, Hakan Göker, Leylagül Kaynar, Ä°smail Sarı, ÃiÄdem Pala, Mehmet Hilmi DoÄu, Erman Ãztürk, Burhan Turgut, Serdal Korkmaz, AyÅegül Tetik, Yahya BüyükaÅık, Sibel Kabukçu HacıoÄlu, Sinem Civriz BozdaÄ, Evren Ãzdemir,